...
首页> 外文期刊>Virulence. >An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for Clostridium perfringens elicits effective anti-toxins protective immunity
【24h】

An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for Clostridium perfringens elicits effective anti-toxins protective immunity

机译:组成型表达产气荚膜梭菌的α,ε,β1和β2类毒素的EGFP标记重组乳杆菌口服四价疫苗引发有效的抗毒素保护性免疫

获取原文
           

摘要

Clostridium perfringens is a common opportunistic pathogen endangering livestock and poultry breeds. Here, using enhanced green fluorescent protein as screening marker, a recombinant lactobacillus tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids of C. perfringens was developed, and its immunogenicity in mice was investigated via oral administration. This probiotic vaccine could effectively induce antigen-specific secretory IgA (sIgA)-based mucosal and IgG-based humoral immune responses, and significantly high levels (p 0.05) of cytokines IL-2, IL-4, IL-10, IL-12, IL-17, and IFN-γ were produced in immunized mice. Moreover, lymphoproliferation and percentage of CD4+ and CD8+ T cells significantly increased in mice of the probiotic vaccine group. Challenge experiments were performed in mice with C. perfringens toxinotypes A, C, and D crude toxins to evaluate protection efficiency of the probiotic vaccine, using a commercial inactivated C. perfringens vaccine made by C. perfringens toxinotypes A, C, and D as vaccine control. We observed 80% protection rate in the probiotic vaccine group, which was higher than commercial vaccine group, whereas all mice in control groups died and obvious histopathological changes were observed in liver, spleen, kidney, and intestines of mice. Significantly, we compared the immunogenicity and protection efficiency of lactobacillus constitutive expression system and lactobacillus inducible expression system, and results showed that lactobacillus constitutive expression system has obvious advantages. Our study clearly demonstrated that the probiotics vaccine could effectively induce mucosal, humoral, and cellular immunity, and provide effective protection against C. perfringens toxins, suggesting a promising strategy for the development of oral vaccine against C. perfringens.
机译:产气荚膜梭状芽胞杆菌是危害牲畜和家禽品种的常见机会病原体。在这里,使用增强的绿色荧光蛋白作为筛选标记,开发了组成型表达产气荚膜梭菌α,ε,β1和β2类毒素的重组乳杆菌四价疫苗,并通过口服研究了其在小鼠中的免疫原性。这种益生菌疫苗可以有效诱导基于抗原特异性分泌性IgA(sIgA)的粘膜和基于IgG的体液免疫反应,并显着高水平(p <0.05)的细胞因子IL-2,IL-4,IL-10,IL-在经免疫的小鼠中产生图12的IL-17和IFN-γ。此外,益生菌疫苗组小鼠的淋巴细胞增殖和CD4 +和CD8 + T细胞百分比显着增加。使用由产气荚膜梭菌毒素A,C和D制成的商业灭活的产气荚膜梭菌疫苗作为疫苗,在具有产气荚膜梭菌毒素A,C和D粗毒素的小鼠中进行攻击实验,以评估益生菌疫苗的保护效率。控制。我们观察到益生菌疫苗组的保护率为80%,高于商业疫苗组,而对照组的所有小鼠都死亡,并且在小鼠的肝,脾,肾和肠中观察到明显的组织病理学变化。有意义的是,我们比较了乳杆菌组成型表达系统和乳杆菌诱导型表达系统的免疫原性和保护效率,结果表明,乳杆菌组成型表达系统具有明显的优势。我们的研究清楚地表明,益生菌疫苗可以有效诱导粘膜,体液和细胞免疫,并提供针对产气荚膜梭菌毒素的有效保护,为开发针对产气荚膜梭菌的口服疫苗提供了有希望的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号